ORC2L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.756800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.711200E-01
Normal-vs-Stage2
9.495000E-01
Normal-vs-Stage3
2.137400E-01
Normal-vs-Stage4
4.075000E-01
Stage1-vs-Stage2
7.550400E-01
Stage1-vs-Stage3
1.390960E-01
Stage1-vs-Stage4
1.993800E-01
Stage2-vs-Stage3
9.442100E-02
Stage2-vs-Stage4
2.902400E-01
Stage3-vs-Stage4
3.086100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.935000E-01
Normal-vs-AfricanAmerican
9.984600E-01
Normal-vs-Asian
9.191000E-01
Caucasian-vs-AfricanAmerican
9.931800E-01
Caucasian-vs-Asian
8.570400E-01
AfricanAmerican-vs-Asian
8.956000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.832400E-01
Normal-vs-Female
9.392600E-01
Male-vs-Female
6.884200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.137600E-01
Normal-vs-Age(41-60Yrs)
8.917600E-01
Normal-vs-Age(61-80Yrs)
9.487400E-01
Normal-vs-Age(81-100Yrs)
8.214400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.286200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.264600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.489200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.831200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.260000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.577800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.088800E-01
Normal-vs-Daily Drinker
7.170400E-01
Normal-vs-Weekly Drinker
7.928400E-01
Normal-vs-Occasional Drinker
9.370200E-01
Normal-vs-Social Drinker
8.927000E-01
Non Drinker-vs-Daily Drinker
7.341400E-01
Non Drinker-vs-Weekly Drinker
4.386600E-01
Non Drinker-vs-Occasional Drinker
4.998200E-01
Non Drinker-vs-Social Drinker
7.702800E-01
Daily Drinker-vs-Weekly Drinker
3.698400E-01
Daily Drinker-vs-Occasional Drinker
3.588800E-01
Daily Drinker-vs-Social Drinker
5.673800E-01
Weekly Drinker-vs-Occasional Drinker
6.137800E-01
Weekly Drinker-vs-Social Drinker
5.110600E-01
Occasional Drinker-vs-Social Drinker
6.911400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.119900E-02
Normal-vs-Grade 2
1.030500E-02
Normal-vs-Grade 3
4.341700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.622340E-02
Grade 1-vs-Grade 3
6.441600E-03
Grade 1-vs-Grade 4
4.119900E-02
Grade 2-vs-Grade 3
5.990600E-01
Grade 2-vs-Grade 4
1.030500E-02
Grade 3-vs-Grade 4
4.341700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.472800E-01
Normal-vs-NonDiabetic
9.780600E-01
Diabetic-vs-NonDiabetic
3.851400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.265600E-01
Normal-vs-NoPancreatitis
9.178000E-01
Pancreatitis-vs-NoPancreatitis
9.554400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.478800E-01
Normal-vs-N1
9.540000E-01
N0-vs-N1
3.901600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.593800E-01
Normal-vs-TP53-NonMutant
9.080400E-01
TP53-Mutant-vs-TP53-NonMutant
2.527600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
